Axonics Balance Sheet Health
Financial Health criteria checks 6/6
Axonics has a total shareholder equity of $664.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $774.2M and $109.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$345.23m |
| Equity | US$664.49m |
| Total liabilities | US$109.68m |
| Total assets | US$774.17m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0I3's short term assets ($525.9M) exceed its short term liabilities ($64.4M).
Long Term Liabilities: 0I3's short term assets ($525.9M) exceed its long term liabilities ($45.3M).
Debt to Equity History and Analysis
Debt Level: 0I3 is debt free.
Reducing Debt: 0I3 has no debt compared to 5 years ago when its debt to equity ratio was 21.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 0I3 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 0I3 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 30.7% per year.